Photo from wikipedia
9. Yip L, Deng JF. Dabigatran reversal with idarucizumab. N Engl J Med 2017; 377: 1690 10. Yip L, Deng JF. The recommended dose of idarucizumab may not always be… Click to show full abstract
9. Yip L, Deng JF. Dabigatran reversal with idarucizumab. N Engl J Med 2017; 377: 1690 10. Yip L, Deng JF. The recommended dose of idarucizumab may not always be sufficient for sustained reversal of dabigatran: Comment. J Thromb Haemost 2017; 15: 2466e7 11. Yip L, Deng JF. Idarucizumab e Antidote for hemorrhage following therapeutic dabigatran dosing? 23 June 2017. https://www.bmj.com/content/357/bmj.j2216/rr 12. Mann KG. Thrombin generation in hemorrhage control and vascular occlusion. Circulation 2011; 124: 225e35 13. Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor-induced blood coagulation. Blood 2002; 100: 148e52 14. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost 2003; 1: 1504e14 15. Yip L, Deng JF. Idarucizumab dosing in kidney failure. Am J Kidney Dis 2018; 71: 146
Journal Title: British journal of anaesthesia
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!